Generics Face Antitrust Suit Over Antidepressant Prices
Generic drug makers Sandoz, Mylan and Par Pharmaceuticals were slapped with an antitrust suit in Pennsylvania federal court on Wednesday, accusing them of colluding to increase the price for amitriptyline, an...To view the full article, register now.
Already a subscriber? Click here to view full article